Source: Annual Congress 2009 - Lung cancer biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Straker, C. Loesecken, P. Fuchs, W. Miekisch, J. Schubert (Rostock, Germany). Exhaled aldehydes as markers of disease in lung cancer patients. Eur Respir J 2009; 34: Suppl. 53, 291

Member's Comments

No comment yet.

Related content which might interest you: Protein markers in the exhaled breath condensate of lung carcinoma patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Exhaled volatile organic compounds as biomarkers for respiratory diseases Source: Eur Respir Monogr 2010; 49: 130-139 Year: 2010 Exhaled MMP-9 in lung cancer Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients? Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011 Dermcidin identification from exhaled air for lung cancer diagnosis Source: Eur Respir J 2010; 35: 1182-1185 Year: 2010 Tumor size and inflammatory cytokines in exhaled breath condensate in patients with non small cell lung cancer (NSCLC) Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 HPV in exhaled breath condensate of lung cancer patients Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Detection of p53 mutation in exhaled breath condensate from patients with nonsmall cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002 Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD) Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Exhaled hydrogen sulfide in patients with chronic airway inflammatory disease Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Exhaled biomarkers in lung cancer Source: Eur Respir J 2009; 34: 261-275 Year: 2009 Exhaled aldehydes as markers of disease in critically ill patients Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007 Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Pretreatment levels of TNF-α in serum and exhaled breath condensate in patients with lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Comparison of exhaled biomarkers to other markers of airway diseases Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013